We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Treatment of Schizophrenia Through Internet-Based Psychoeducation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00051233
Recruitment Status : Completed
First Posted : January 8, 2003
Last Update Posted : June 30, 2014
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Pittsburgh

Brief Summary:
The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.

Condition or disease Intervention/treatment Phase
Schizophrenia Schizoaffective Disorder Procedure: World Wide Web-Based Psychoeducation Phase 2

Detailed Description:

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being.

Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Schizophrenia Patient and Family Continuity of Care
Study Start Date : January 2003
Estimated Study Completion Date : January 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   14 Years to 55 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • At least 4 hours/week in-person contact with a family member
  • Primary caregiver with a telephone
  • Patient and primary caregiver speak and read English

Exclusion Criteria:

  • Enrolled in another clinical trial
  • Evidence of organic brain syndrome
  • Current alcohol or substance abuse that could explain the presenting index psychotic episode
  • DSM-IV diagnosis of psychoactive substance dependency

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00051233

United States, Pennsylvania
University of Pittsburgh Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania, United States, 15261
Sponsors and Collaborators
University of Pittsburgh
National Institute of Mental Health (NIMH)
Principal Investigator: Armando J Rotondi University of Pittsburgh

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00051233     History of Changes
Other Study ID Numbers: R01MH063484 ( U.S. NIH Grant/Contract )
First Posted: January 8, 2003    Key Record Dates
Last Update Posted: June 30, 2014
Last Verified: June 2014

Additional relevant MeSH terms:
Psychotic Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders